Roth Capital Starts AMAG Pharmaceuticals (AMAG) at Buy
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Join SI Premium – FREE
Roth Capital initiates coverage on AMAG Pharmaceuticals (NASDAQ: AMAG) with a Buy rating and $25 price target.
For more ratings news on AMAG Pharmaceuticals click here and for the rating history of AMAG Pharmaceuticals click here.
Shares of AMAG Pharmaceuticals closed at $17.33 yesterday.
For more ratings news on AMAG Pharmaceuticals click here and for the rating history of AMAG Pharmaceuticals click here.
Shares of AMAG Pharmaceuticals closed at $17.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Equirus Starts JSW Energy Ltd (JSW:IN) at Long (1)
- Nomura/Instinet Starts Weichai Power Co Ltd (000338:CH) (WEICY) at Buy
- Macquarie Starts Zhejiang Jiuli Hi-Tech Metals (002318:CH) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
